Consensus NOV Inc.

Stocks

NOV

US62955J1034

Oil Related Services and Equipment

Real-time Estimate Cboe BZX 04:38:59 30/10/26 am AEDT			5-day change	1st Jan Change
19.30 ^USD	+0.18%		+2.88%	+23.48%

29/10	NOV Inc., Q3 2026 Earnings Call, Oct 28, 2026
28/10	Earnings Flash (NOV) NOV Inc. Reports Q3 Revenue $2.23B, vs. FactSet Est of $2.20B	MT

Evolution of the Average Target: NOV Inc.

Evolution of the Target Price: NOV Inc.

Changes in Analyst Recommendations: NOV Inc.

0272f4d3977f67d5fc1c6f2fb2a84.3I0LdFzstw_GNUYLSJTeRR6ejHpX6IljfgLNahEslQg.6qBmBgSd1H2qUiJzPuCcHU7Z0wgTt7s6PzKdGmB90kykoEYNNd_gQYR_Bw~56d2c2d3cddfa6c256c777560cf57f80

Analysts' recommendations: NOV Inc.

05/06	NOV Shares Rise After Capital One Upgrade	MT
04/06	Capital One Upgrades NOV to Overweight From Equal Weight, Adjusts Price Target to $26 From $25	MT
01/05	Zephirin Cuts Price Target on NOV to $17 From $18, Keeps Hold Rating, Medium Risk	MT
29/04	RBC Lifts Price Target on NOV to $22 From $21, Keeps Sector Perform Rating	MT
15/04	NOV Offers Upside From Improved Offshore and Short-Cycle Activity but Better Alternatives Exist, RBC Says	MT
14/04	RBC Downgrades NOV to Sector Perform From Outperform, Keeps $21 Price Target	MT
14/04	Analyst recommendations: Biogen, Ford, Ge Vernova, Booking, Comcast…
23/02	Zephirin Downgrades NOV to Hold From Buy, Lifts Price Target to $18 From $17, Keeps Medium Risk	MT
12/02	Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap…
05/02	Barclays Upgrades NOV to Equalweight From Underweight, Raises Price Target to $20 From $15	MT
04/02	Analyst recommendations: Booking, PayPal, Fedex, Gartner, Lockheed Martin….
16/01	RBC Capital Adjusts NOV Price Target to $21 From $19, Maintains Outperform Rating	MT
14/01	Analyst recommendations: Rivian, Applied Materials, Coinbase, Intel, Spotify…
21/11	Zephirin Lowers Price Target on NOV to $16 From $17, Keeps Buy Rating	MT
29/10/25	RBC Raises Price Target on NOV to $19 From $17, Keeps Outperform Rating	MT
09/10/25	RBC Lowers Price Target on NOV to $17 From $18, Keeps Outperform Rating	MT
30/07/25	RBC Cuts Price Target on NOV to $18 From $19, Keeps Outperform Rating	MT
29/07/25	NOV's Q2 revenue falls but beats expectations	RE
15/05/25	Zephirin Cuts Price Target on NOV to $17 From $19, Keeps Buy Rating	MT
30/04/25	RBC Trims Price Target on NOV to $19 From $20, Keeps Outperform Rating	MT
24/03/25	Analyst recommendations: General Mills, Ulta Beauty, Micron Technology, RH…
24/03/25	RBC Upgrades NOV to Outperform From Sector Perform, Maintains $22 Price Target	MT
06/02/25	RBC Raises Price Target on NOV to $22 From $21, Keeps Sector Perform Rating	MT
15/01/25	Evercore ISI Downgrades NOV to In Line From Outperform, Adjusts Price Target to $18 From $25	MT
07/01/25	Seaport Downgrades NOV to Neutral From Buy	MT

More recommendations

Other Oil Related Services and Equipment

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	NOV INC.					+14.58%
	SLB N.V.					+16.05%
	BAKER HUGHES COMPANY					+29.51%
	TENARIS S.A.					+4.42%
	HALLIBURTON COMPANY					+22.15%
	TECHNIPFMC PLC					+7.02%
	YANTAI JEREH OILFIELD SERVICES GROUP CO., LTD.					+102.54%
	SUBSEA 7 S.A.					+10.08%
	SAIPEM SPA					+9.91%
	WEATHERFORD INTERNATIONAL PLC					+27.05%
	Average					+24.33%
	Weighted average by Cap.					+21.55%